Digital rheumatology in the era of COVID-19: results of a national patient and physician survey.
Adolescent
Adult
Aged
Aged, 80 and over
COVID-19
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Musculoskeletal Diseases
/ therapy
Patient Acceptance of Health Care
/ statistics & numerical data
Prospective Studies
Rheumatologists
/ statistics & numerical data
Surveys and Questionnaires
Telemedicine
Young Adult
COVID-19
epidemiology
health services research
patient reported outcome measures
Journal
RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
14
12
2020
revised:
12
02
2021
accepted:
15
02
2021
entrez:
24
2
2021
pubmed:
25
2
2021
medline:
5
3
2021
Statut:
ppublish
Résumé
To analyse the impact of the COVID-19 pandemic on rheumatic patients' and rheumatologists' usage, preferences and perception of digital health applications (DHAs). A web-based national survey was developed by the Working Group Young Rheumatology of the German Society for Rheumatology and the German League against Rheumatism. The prospective survey was distributed via social media (Twitter, Instagram and Facebook), QR code and email. Descriptive statistics were calculated, and regression analyses were performed to show correlations. We analysed the responses of 299 patients and 129 rheumatologists. Most patients (74%) and rheumatologists (76%) believed that DHAs are useful in the management of rheumatic and musculoskeletal diseases (RMDs) and felt confident in their own usage thereof (90%; 86%). 38% of patients and 71% of rheumatologists reported that their attitude had changed positively towards DHAs and that their usage had increased due to COVID-19 (29%; 48%). The majority in both groups agreed on implementing virtual visits for follow-up appointments in stable disease conditions. The most reported advantages of DHAs were usage independent of time and place (76.6%; 77.5%). The main barriers were a lack of information on suitable, available DHAs (58.5%; 41.9%), poor usability (42.1% of patients) and a lack of evidence supporting the effectiveness of DHAs (23.2% of rheumatologists). Only a minority (<10% in both groups) believed that digitalisation has a negative impact on the patient-doctor relationship. The COVID-19 pandemic instigated an increase in patients' and rheumatologists' acceptance and usage of DHAs, possibly introducing a permanent paradigm shift in the management of RMDs.
Identifiants
pubmed: 33622673
pii: rmdopen-2020-001548
doi: 10.1136/rmdopen-2020-001548
pmc: PMC7907631
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JMIR Mhealth Uhealth. 2020 Aug 12;8(8):e19661
pubmed: 32678796
Joint Bone Spine. 2020 Jan;87(1):69-73
pubmed: 31369867
BMC Musculoskelet Disord. 2016 Aug 24;17(1):362
pubmed: 27553253
Ann Rheum Dis. 2020 Sep;79(9):1139-1140
pubmed: 32527863
Ann Rheum Dis. 2020 Jun 5;:
pubmed: 32503851
Ann Rheum Dis. 2020 Jun;79(6):740-743
pubmed: 32209541
Ann Rheum Dis. 2015 Jan;74(1):8-13
pubmed: 25261577
Semin Arthritis Rheum. 2016 Dec;46(3):380-385
pubmed: 27395561
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
Z Rheumatol. 2019 Nov;78(9):839-846
pubmed: 30542914
NPJ Digit Med. 2020 Jul 10;3:94
pubmed: 32685700
JMIR Mhealth Uhealth. 2020 May 15;8(5):e17507
pubmed: 32348258
Nat Rev Rheumatol. 2020 Sep;16(9):525-535
pubmed: 32709998
JAMA Intern Med. 2019 Jul 29;:
pubmed: 31355849
J Gen Intern Med. 2020 Jun;35(6):1751-1758
pubmed: 32016705
Ann Rheum Dis. 2020 Jun 5;:
pubmed: 32503860
JMIR Mhealth Uhealth. 2019 Aug 05;7(8):e14991
pubmed: 31381501
Arthritis Care Res (Hoboken). 2019 Oct;71(10):1336-1343
pubmed: 30242992
BMJ. 2020 Nov 10;371:m4348
pubmed: 33172855
RMD Open. 2020 Oct;6(3):
pubmed: 33011680
PLoS One. 2020 Sep 28;15(9):e0238658
pubmed: 32986733
RMD Open. 2019 Sep 13;5(2):e001014
pubmed: 31565245
Dtsch Med Wochenschr. 2019 Apr;144(7):e3
pubmed: 31284312
Ann Rheum Dis. 2020 Nov 6;:
pubmed: 33158877
Arthritis Care Res (Hoboken). 2020 Oct 14;:
pubmed: 33053261
Rheumatol Int. 2018 Nov;38(11):1949-1957
pubmed: 29713795
Z Rheumatol. 2020 Aug;79(6):562-569
pubmed: 32651681
JMIR Mhealth Uhealth. 2020 Jul 20;8(7):e18117
pubmed: 32390592
Int J Rheum Dis. 2020 Dec;23(12):1645-1650
pubmed: 33089956
Ann Rheum Dis. 2018 Jul;77(7):963-965
pubmed: 29802224
Z Rheumatol. 2020 Aug;79(6):584-589
pubmed: 32661916